A new ligand for the urotensin II receptor
- 1 October 2002
- journal article
- Published by Wiley in British Journal of Pharmacology
- Vol. 137 (3) , 311-314
- https://doi.org/10.1038/sj.bjp.0704895
Abstract
The cyclic peptide human urotensin II (U-II) has been recently recognized as the endogenous ligand of an orphan GPCR, subsequently named the UT receptor. No synthetic ligands are available for investigating this novel peptide-receptor system. A novel UT receptor ligand, [Orn(8)]U-II, was synthesized and evaluated in calcium functional assays performed on HEK293 cells expressing the recombinant rat and human UT receptor and in the rat aorta bioassay. [Orn(8)]U-II behaves as a full agonist (pEC(50) approximately equal 8) at both human and rat UT receptors in the FlipR calcium assay eliciting similar maximal effects as the natural ligand U-II. On the contrary, in the rat aorta bioassay, [Orn(8)]U-II behaves as a competitive and selective antagonist (pA(2)=6.56) showing however a small but consistent residual agonist activity. It is therefore proposed that [Orn(8)]U-II is a partial agonist at UT receptors.Keywords
This publication has 14 references indexed in Scilit:
- Drug Efficacy at G Protein–Coupled ReceptorsAnnual Review of Pharmacology and Toxicology, 2002
- Identification of Nonpeptidic Urotensin II Receptor Antagonists by Virtual Screening Based on a Pharmacophore Model Derived from Structure−Activity Relationships and Nuclear Magnetic Resonance Studies on Urotensin IIJournal of Medicinal Chemistry, 2002
- Effects of human urotensin II in isolated vessels of various species; comparison with other vasoactive agentsNaunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 2002
- Differential vasoconstrictor activity of human urotensin‐II in vascular tissue isolated from the rat, mouse, dog, pig, marmoset and cynomolgus monkeyBritish Journal of Pharmacology, 2000
- Orphan‐receptor ligand human urotensin II: receptor localization in human tissues and comparison of vasoconstrictor responses with endothelin‐1British Journal of Pharmacology, 2000
- Human Urotensin-II, the Most Potent Mammalian Vasoconstrictor Identified To Date, as a Therapeutic Target for the Management of Cardiovascular DiseaseTrends in Cardiovascular Medicine, 2000
- Pharmacology of nociceptin and its receptor: a novel therapeutic targetBritish Journal of Pharmacology, 2000
- Pharmacological characterisation of the first non-peptide bradykinin B2 receptor agonist FR 190997: an in vitro study on human, rabbit and pig vascular B2 receptorsNaunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1999
- Human urotensin-II is a potent vasoconstrictor and agonist for the orphan receptor GPR14Nature, 1999
- Identification of the natural ligand of an orphan G-protein-coupled receptor involved in the regulation of vasoconstrictionNature Cell Biology, 1999